Stimuvax is an investigational therapeutic vaccine for treatment of advanced non-small cell lung cancer (NSCLC) and breast tumours.
-
Stimuvax is an investigational therapeutic vaccine for treatment of advanced... -
Stimuvax is designed to provide immunity against the cancer cells that over... -
Stimuvax was the first investigational cancer vaccine to enrol patients for... -
The Phase III clinical trial of Stimuvax, INSPIRE, was started on 10 December...